Φορτώνει......
Efficacy of oral moxidectin against susceptible and resistant isolates of Dirofilaria immitis in dogs
BACKGROUND: Monthly topical and sustained-release injectable formulations of moxidectin are currently marketed; however, an oral formulation, while approved at a dose of 3 μg/kg, is not currently marketed in the United States. Although resistance of heartworms to all macrocyclic lactone (ML) heartwo...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Parasit Vectors |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5688394/ https://ncbi.nlm.nih.gov/pubmed/29143634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13071-017-2429-5 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|